Bristol Myers Squibb (NYSE: BMY) reported its fourth quarter 2025 earnings outcomes immediately.
Revenues elevated 1% year-over-year to $12.5 billion.
GAAP web earnings attributable to Bristol Myers Squibb was $1.1 billion, or $0.53 per share, versus $72 million, or $0.04 per share, final 12 months. Adjusted EPS decreased 25% to $1.26.
US revenues had been $8.6 billion whereas worldwide revenues had been $3.9 billion.
For fiscal 12 months 2026, the corporate expects complete revenues to be $46.0-47.5 billion and adjusted EPS to be $6.05-6.35.
Commercial
Source link
#Bristol #Myers #Squibb #BMY #Earnings #4Q25 #Key #Numbers #AlphaStreet
